[ European Foundation For the Study of Diabetes (EFSD) and Servier I Research funding on treatment adherence for people with diabetes ]

The European Foundation for the Study of Diabetes (EFSD) launches the call for tenders INTENSE Project: ImproviNg Treatment adhErence iN people with diabeteS mEllitus, which is supported, in part, by the French pharmaceutical company Servier.
 
The primary goal of this call for tender is to identify strategies enabling people with type 2 diabetes, their carers and health care professionals to improve sustained adherence to the mutually agreed treatment plan.
 
The project should include but not necessarily be restricted to the following objectives:

1. Develop and validate new tools or implement existing methodology in the area of research (e.g. assessment tools, outcome measures, use of big data)
2. Develop and validate new technology or implement existing technology (e.g. mobile technology/mHealth and associated apps, eHealth, social networking…)
3. Develop and validate new interventions or implement evidence-based interventions to improve sustained adherence (on the level of patients, healthcare professionals, carers and/or health care system)
4. Evaluate biomedical, economic and patient reported outcomes, and their relationship to adherence

• clinical research groups based in the EU or Associated Countries.
• The PI and Co-PIs must be employed full-time at a non-profit institution and the study must be performed at their place of work.
• Applicants to all EFSD programmes must be .
• Only one EFSD award per PI or Co-PI at a time.
• There can be more than one EFSD award per lab, but for separate projects.

• Max. EUR 500’000 for 36 months.
• The budget must be prepared in EUR and it must mention the exchange rate.
• Please mention all funding requested and obtained from other sources.
• Eligible costs: personnel, 10% OH, equipment, supplies, other project-related costs.